Research & Publications
Dr. Lieping Chen is an immunologist interested in basic T cell biology, cancer immunology, and translational research to develop new treatments for human diseases including cancer. Prior to joining Yale, he was a faculty member at Johns Hopkins University School of Medicine and Mayo Clinic, and a scientist for the company - Bristol-Myers Squibb.
Dr. Chen has published over 370 peer-reviewed research articles. His work in the discovery of the PD-1/PD-L1 pathway for cancer immunotherapy was cited as the #1 breakthrough of the year by Science magazine in 2013. He is a member of the National Academy of Sciences and a fellow of the American Association for Cancer Research.
Education & Training
- PhDDrexel University, Pathology and Laboratory Medicine (1989)
- MSBeijing Union Medical College, Immunology (1986)
- MDFujian Medical College (1982)
Honors & Recognition
|Fellow||Society for Immunotherapy of Cancer||2021|
|Fellow||American Association for Cancer Research||2021|
|Elected Member||National Academy of Sciences||2021|
|Richard V. Smalley MD Memorial Award||Society for Immunotherapy of Cancer||2020|
|Warren Alpert Foundation Prize||Warren Alpert Foundation||2017|
|AAI-Steinman Award||American Association of Immunologists||2016|
|William B. Coley Award||Cancer Research Institute||2014|